Prostate Cancer - Results from #28460

Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival - Abstract March 11, 2011

Editor's Commentary - The influence of family history on prostate cancer risk: Implications for clinical management March 11, 2011

Impact of genotyping on outcome of prostatic biopsies: A multicentre prospective study - Abstract March 10, 2011

Distribution of the lymphatic vessels in the prostatic fascia - Abstract March 10, 2011

High-dose-rate brachytherapy boost to the dominant intra-prostatic tumor region: Hemi-irradiation of prostate cancer - Abstract March 10, 2011

Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benign prostate hyperplasia? - Abstract March 10, 2011

Docetaxel-mediated apoptosis in myeloid progenitor TF-1 cells is mitigated by zinc: Potential implication for prostate cancer therapy - Abstract March 10, 2011

Vitamin D insufficiency is common in patients with nonmetastatic prostate cancer - Abstract March 10, 2011

High-dose-rate monotherapy: Safe and effective brachytherapy for patients with localized prostate cancer - Abstract March 10, 2011

Benchmarking dosimetric quality assessment of prostate intensity-modulated radiotherapy - Abstract March 10, 2011

Predicting pelvic lymph node involvement in current-era prostate cancer - Abstract March 9, 2011

Screening and diagnosis of prostate cancer in patients with ileal pouch-anal anastomosis: Consensus from an expert panel - Abstract March 9, 2011

Monte Carlo calculation of imaging doses from diagnostic multidetector CT and kilovoltage cone-beam CT as part of prostate cancer treatment plans - Abstract March 9, 2011

Multimodal microscopy for automated histologic analysis of prostate cancer - Abstract March 9, 2011

Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients - Abstract March 9, 2011

Muscle endurance, cancer-related fatigue, and radiotherapy in prostate cancer survivors - Abstract March 9, 2011

Results of high dose-rate brachytherapy boost before 2D or 3D external beam irradiation for prostate cancer - Abstract March 8, 2011

Androgen regulation of prostate cancer: Where are we now? - Abstract March 8, 2011

Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes, and cardiovascular disease: A review - Abstract March 8, 2011

PSA-based prostate cancer screening: The role of active surveillance and informed and shared decision making - Abstract March 8, 2011

Page 1424 of 1435